You just read:

Ionis Pharmaceuticals Reports Data Update from Nusinersen Phase 2 Study in Infants with Spinal Muscular Atrophy and Reviews Neurological Disease Franchise

News provided by

Ionis Pharmaceuticals, Inc.

20 Apr, 2016, 11:30 ET